| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2024 | Mar 15, 2024 | Traws Pharma, Inc. | CEO | Sell | 27.5 | -8,727 | -10.45% | ✗ | $7.9K |
| Feb 7, 2024 | Feb 9, 2024 | Traws Pharma, Inc. | CEO | Sell | 27.5 | -9,212 | -13.23% | ✗ | $6.2K |
| Aug 2, 2023 | Aug 4, 2023 | Traws Pharma, Inc. | CEO | Sell | 27.5 | -4,744 | -8.94% | ✗ | $4.8K |
| Feb 7, 2023 | Feb 8, 2023 | Traws Pharma, Inc. | CEO | Sell | 27.5 | -6,977 | -14.70% | ✗ | $9.5K |
| Aug 2, 2022 | Aug 4, 2022 | Traws Pharma, Inc. | CEO | Sell | 27.5 | -4,562 | -14.86% | ✗ | $6K |
| Sep 28, 2021 | Sep 28, 2021 | Traws Pharma, Inc. | CEO | Buy | 91.3 | +2,381 | 15.12% | ✗ | $10K |
| Feb 16, 2021 | Feb 17, 2021 | Traws Pharma, Inc. | CEO | Buy | 86.3 | +20,000 | 9.25% | ✗ | $20K |
| Nov 25, 2020 | Nov 30, 2020 | Traws Pharma, Inc. | CEO | Buy | 91.3 | +40,000 | 22.70% | ✗ | $10.4K |
| May 19, 2020 | May 20, 2020 | Traws Pharma, Inc. | CEO | Buy | 90.0 | +26,800 | 17.94% | ✗ | $9.9K |
| Nov 25, 2019 | Nov 26, 2019 | Traws Pharma, Inc. | CEO | Buy | 91.3 | +149,000 | 34976.53% | ✗ | $29.8K |